Sanofi pulls phase 3 trial of $3.7B drug as competition heats up
Sanofi Microbiosys Digestive Comfort 30 capsules - Walmart.com
Unable to 'align' with FDA, Regeneron, Sanofi pull application for Libtayo in cervical cancer days before decision date | Fierce Pharma
BioCentury - After latest clinical disappointment, Sanofi pulls plug on SERD
Reaction 'excessive' to Sanofi's upcoming litigation: analysts
Sanofi Trial Failure Halts Work on Breast Cancer Treatment Amcenestrant
Sanofi Strategy Under CEO Paul Hudson: Capital Markets Day Slides
Sanofi ordered to pull dengue vaccine | Business | Chemistry World
Sanofi, Regeneron's Praluent pulls off PCSK9 coup with 29% cut to death risks in most vulnerable patients | Fierce Pharma
Sanofi raises profit forecast following positive Q2 results - PMLiVE
Dupixent continues to grow with new US indication
Sanofi pulls Lyxumia's US filing - PMLiVE
Sanofi pulls IGM into dealmaking whirlwind, paying $150M upfront to form 6-target R&D pact | Fierce Biotech
Sanofi abandoning Auvi-Q after dosage problems led to total recall
Dupixent sales of €10B? We're on track, Sanofi CEO Hudson says | Fierce Pharma
Sanofi Might Pull Down Shutters For Two Vaccine Plants In India
Sanofi pulls out of Zika vaccine collaboration as feds gut its R&D contract | Fierce Pharma
Sanofi pulls out of Dagenham | Pharmafile
